81R4236 JSC-D
 
  By: Woolley H.B. No. 1764
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the regulation of the use of human cells and tissue,
  including a ban on human cloning; providing penalties.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subtitle H, Title 2, Health and Safety Code, is
  amended by adding Chapter 176 to read as follows:
  CHAPTER 176.  BIOMEDICAL RESEARCH OVERSIGHT
  SUBCHAPTER A.  GENERAL PROVISIONS
         Sec. 176.001.  DEFINITIONS.  In this chapter:
               (1)  "Embryo" means an organism from the single cell
  stage to eight weeks of development.
               (2)  "Fertilization" means the fusion of a female germ
  cell containing a haploid nucleus with a male gamete or sperm cell.
               (3)  "Human cloning" means implanting or attempting to
  implant into a uterus or the functional equivalent of a uterus a
  human embryo created by a method other than fertilization.
               (4)  "Oocyte" means the female germ cell, the egg.
  [Sections 176.002-176.050 reserved for expansion]
  SUBCHAPTER B.  HUMAN CLONING
         Sec. 176.051.  HUMAN CLONING PROHIBITED.  A person may not
  engage in or attempt to engage in human cloning.
         Sec. 176.052.  LICENSED VIOLATORS. A person licensed by a
  state agency as a health care practitioner or health care facility
  who violates Section 176.051 is subject to the same consequence,
  other than a civil penalty, that the person would be subject to if
  the person had violated the licensing law applicable to the person
  or rules adopted under that law.
         Sec. 176.053.  CIVIL PENALTY. (a)  A person who violates
  Section 176.051 is liable to the state for a civil penalty of not
  more than $10 million for each violation.
         (b)  The amount of the penalty shall be based on:
               (1)  the seriousness of the violation;
               (2)  the history of previous violations;
               (3)  the amount necessary to deter a future violation;
  and
               (4)  any other matter that justice may require.
         (c)  The attorney general may sue to collect a civil penalty
  under this section.  In the suit the attorney general may recover
  the reasonable expenses incurred in obtaining the penalty,
  including investigation and court costs, reasonable attorney's
  fees, witness fees, and other expenses.
         Sec. 176.054.  CRIMINAL OFFENSE.  A person commits an
  offense if the person intentionally engages in or attempts to
  engage in human cloning.  An offense under this section is a felony
  of the first degree.
  [Sections 176.055-176.100 reserved for expansion]
  SUBCHAPTER C.  RESEARCH USING CERTAIN HUMAN CELLS OR TISSUES
         Sec. 176.101.  PROTECTION OF RESEARCH.  This chapter does
  not restrict or prohibit:
               (1)  scientific research, including nuclear
  transplantation, to develop regenerative or reparative medical
  therapies or treatments; or
               (2)  any other research not specifically prohibited by
  this chapter.
         Sec. 176.102.  RESEARCH OVERSIGHT. Research described by
  Section 176.101(1) must be:
               (1)  conducted with full consideration for the ethical
  and medical implications of the research; and
               (2)  reviewed, in each case, by an institutional review
  board for compliance with applicable state and federal law and
  after consideration of the guidelines developed under Section
  176.103.
         Sec. 176.103.  ADVISORY COMMITTEE ON RESEARCH TO DEVELOP
  REGENERATIVE OR REPARATIVE MEDICAL THERAPIES OR TREATMENTS.  (a)  
  The executive commissioner of the Health and Human Services
  Commission shall establish an advisory committee to develop
  guidelines for research described by Section 176.101(1).
         (b)  The advisory committee consists of members appointed by
  the executive commissioner of the Health and Human Services
  Commission as follows:
               (1)  seven scientists with experience in biomedical
  research in the fields of cell differentiation, nuclear
  reprogramming, tissue formation and regeneration, stem cell
  biology, developmental biology, regenerative medicine, or related
  fields;
               (2)  one representative from each health science center
  in this state;
               (3)  one person who is a member of or leader in the
  biotechnology industry;
               (4)  one medical ethicist;
               (5)  one person with a background in legal issues
  related to research described by Section 176.101(1), in vitro
  fertilization, or family law, as it applies to the donation of
  embryos and oocytes; and
               (6)  one person who is a member or leader of a religious
  organization.
         (c)  The advisory committee shall revise and update the
  guidelines developed under this section as necessary.
         (d)  The advisory committee may work with existing
  institutional review boards in developing guidelines.
         (e)  Section 2110.008, Government Code, does not apply to the
  advisory committee.
         Sec. 176.104.  VOLUNTARY DONATION OF OOCYTES.  A person may
  not use an oocyte in nuclear transplantation research unless the
  oocyte was donated voluntarily by and with the informed consent of
  the woman donating the oocyte.
  [Sections 176.105-176.150 reserved for expansion]
  SUBCHAPTER D.  PROHIBITED PURCHASE OR SALE; CRIMINAL PENALTY
         Sec. 176.151.  PURCHASE OR SALE OF OOCYTE.  (a)  A person may
  not purchase, sell, or otherwise transfer for valuable
  consideration a human oocyte.
         (b)  In this section, "valuable consideration" does not
  include reasonable payments:
               (1)  associated with the transportation, processing,
  preservation, or storage of a human oocyte; or
               (2)  to compensate a donor for expenses directly
  associated with the donation.
         (c)  A person commits an offense if the person knowingly
  violates Subsection (a). An offense under this subsection is a
  felony of the first degree.
         SECTION 2.  (a)  The executive commissioner of the Health and
  Human Services Commission shall appoint members to the advisory
  committee as required by Section 176.103, Health and Safety Code,
  as added by this Act, not later than November 1, 2009.
         (b)  The advisory committee shall adopt research guidelines
  as required by Section 176.103, Health and Safety Code, as added by
  this Act, not later than June 1, 2010.
         SECTION 3.  This Act takes effect September 1, 2009.